Now up at Health Affairs Forefront, Kristi Martin and I analyze the published explanations for the 2027 cycle of the Medicare drug price negotiation program. We focus on what's in (and what's not in) the explanations, as well as implications for future cycles. www.healthaffairs.org/content/fore...
Information from CMS’s published explanations of the Medicare Drug Price Negotiation Program negotiated prices for 2027 will help manufacturers and other stakeholders meaningfully engage in the negoti...
